Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24

Eun Jung Jun, Young Ran Nam, Jeonghyun Ahn, Hungwon Tchah, Chul Hyun Joo, Youngmee Jee, Yoo Kyum Kim, Heuiran Lee

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Coxsackievirus A24 (CVA24) is responsible for acute hemorrhagic conjunctivitis, a highly contagious eye disease for which no prevention or treatment is currently available. We thus assessed the antiviral potential of a small interfering RNA (siRNA) targeting CVA24. HeLa cells with or without four different siRNAs complementary to 2C or 3D genome region, were challenged with various CVA24s. Among several siRNAs, a siRNA targeting the highly conserved genome region called the cis-acting replication element (CVA24-CRE), was the only siRNA that decreased virus replication and subsequent cytotoxicity by both CVA24 variant and clinical isolates. Furthermore, CVA24-CRE had effective antiviral activity against CVA24 in primary human conjunctival cells. In addition, CVA24-CRE was highly resistant to the emergence of genetically altered escape mutants. Collectively, the present study provides evidence that CVA24-CRE targeting a conserved viral genome region had universal, prolonged anti-CVA24 activity. This siRNA may thus hold a potential to act clinically as a novel anti-CVA24 agent.

Original languageEnglish (US)
Pages (from-to)389-394
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume376
Issue number2
DOIs
StatePublished - Nov 14 2008
Externally publishedYes

Fingerprint

Enterovirus
Small Interfering RNA
Antiviral Agents
Genes
Cytotoxicity
Viruses
Human Enterovirus C
Acute Hemorrhagic Conjunctivitis
Genome
Eye Diseases
Viral Genome
RNA Viruses
Virus Replication
HeLa Cells

Keywords

  • Acute hemorrhagic conjunctivitis
  • Antiviral effect
  • cis-Acting replication element
  • Coxsackievirus A24
  • Small-interfering RNA

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24. / Jun, Eun Jung; Nam, Young Ran; Ahn, Jeonghyun; Tchah, Hungwon; Joo, Chul Hyun; Jee, Youngmee; Kim, Yoo Kyum; Lee, Heuiran.

In: Biochemical and Biophysical Research Communications, Vol. 376, No. 2, 14.11.2008, p. 389-394.

Research output: Contribution to journalArticle

Jun, Eun Jung ; Nam, Young Ran ; Ahn, Jeonghyun ; Tchah, Hungwon ; Joo, Chul Hyun ; Jee, Youngmee ; Kim, Yoo Kyum ; Lee, Heuiran. / Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24. In: Biochemical and Biophysical Research Communications. 2008 ; Vol. 376, No. 2. pp. 389-394.
@article{a6323e5a2f154e199966a4cfc0b0f15b,
title = "Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24",
abstract = "Coxsackievirus A24 (CVA24) is responsible for acute hemorrhagic conjunctivitis, a highly contagious eye disease for which no prevention or treatment is currently available. We thus assessed the antiviral potential of a small interfering RNA (siRNA) targeting CVA24. HeLa cells with or without four different siRNAs complementary to 2C or 3D genome region, were challenged with various CVA24s. Among several siRNAs, a siRNA targeting the highly conserved genome region called the cis-acting replication element (CVA24-CRE), was the only siRNA that decreased virus replication and subsequent cytotoxicity by both CVA24 variant and clinical isolates. Furthermore, CVA24-CRE had effective antiviral activity against CVA24 in primary human conjunctival cells. In addition, CVA24-CRE was highly resistant to the emergence of genetically altered escape mutants. Collectively, the present study provides evidence that CVA24-CRE targeting a conserved viral genome region had universal, prolonged anti-CVA24 activity. This siRNA may thus hold a potential to act clinically as a novel anti-CVA24 agent.",
keywords = "Acute hemorrhagic conjunctivitis, Antiviral effect, cis-Acting replication element, Coxsackievirus A24, Small-interfering RNA",
author = "Jun, {Eun Jung} and Nam, {Young Ran} and Jeonghyun Ahn and Hungwon Tchah and Joo, {Chul Hyun} and Youngmee Jee and Kim, {Yoo Kyum} and Heuiran Lee",
year = "2008",
month = "11",
day = "14",
doi = "10.1016/j.bbrc.2008.08.169",
language = "English (US)",
volume = "376",
pages = "389--394",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24

AU - Jun, Eun Jung

AU - Nam, Young Ran

AU - Ahn, Jeonghyun

AU - Tchah, Hungwon

AU - Joo, Chul Hyun

AU - Jee, Youngmee

AU - Kim, Yoo Kyum

AU - Lee, Heuiran

PY - 2008/11/14

Y1 - 2008/11/14

N2 - Coxsackievirus A24 (CVA24) is responsible for acute hemorrhagic conjunctivitis, a highly contagious eye disease for which no prevention or treatment is currently available. We thus assessed the antiviral potential of a small interfering RNA (siRNA) targeting CVA24. HeLa cells with or without four different siRNAs complementary to 2C or 3D genome region, were challenged with various CVA24s. Among several siRNAs, a siRNA targeting the highly conserved genome region called the cis-acting replication element (CVA24-CRE), was the only siRNA that decreased virus replication and subsequent cytotoxicity by both CVA24 variant and clinical isolates. Furthermore, CVA24-CRE had effective antiviral activity against CVA24 in primary human conjunctival cells. In addition, CVA24-CRE was highly resistant to the emergence of genetically altered escape mutants. Collectively, the present study provides evidence that CVA24-CRE targeting a conserved viral genome region had universal, prolonged anti-CVA24 activity. This siRNA may thus hold a potential to act clinically as a novel anti-CVA24 agent.

AB - Coxsackievirus A24 (CVA24) is responsible for acute hemorrhagic conjunctivitis, a highly contagious eye disease for which no prevention or treatment is currently available. We thus assessed the antiviral potential of a small interfering RNA (siRNA) targeting CVA24. HeLa cells with or without four different siRNAs complementary to 2C or 3D genome region, were challenged with various CVA24s. Among several siRNAs, a siRNA targeting the highly conserved genome region called the cis-acting replication element (CVA24-CRE), was the only siRNA that decreased virus replication and subsequent cytotoxicity by both CVA24 variant and clinical isolates. Furthermore, CVA24-CRE had effective antiviral activity against CVA24 in primary human conjunctival cells. In addition, CVA24-CRE was highly resistant to the emergence of genetically altered escape mutants. Collectively, the present study provides evidence that CVA24-CRE targeting a conserved viral genome region had universal, prolonged anti-CVA24 activity. This siRNA may thus hold a potential to act clinically as a novel anti-CVA24 agent.

KW - Acute hemorrhagic conjunctivitis

KW - Antiviral effect

KW - cis-Acting replication element

KW - Coxsackievirus A24

KW - Small-interfering RNA

UR - http://www.scopus.com/inward/record.url?scp=53149138899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53149138899&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2008.08.169

DO - 10.1016/j.bbrc.2008.08.169

M3 - Article

VL - 376

SP - 389

EP - 394

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -